Articles by Daniel Marsh
Hawaiian Electric Cuts Storm Outages in Half, Yet 89K Customers Still Dark
Hawaiian Electric reduced Tropical Storm Lala outages by 50.3%, but 88,670 customers remain without power. Restoration costs undisclosed as company faces earnings pressure.
Kenvue Tumbles 2.1% as Kimberly-Clark Deal Mechanics Drive Decline
Kenvue shares dropped 2.1% on Monday, with nearly 88% of the decline linked to Kimberly-Clark's falling stock price in the merger exchange ratio. Acetaminophen search interest rose but no FDA action.
Nvidia's $105B OpenAI Guarantee Sparks Scrutiny as Shares Barely Budge
Nvidia's $105B guarantee for OpenAI's Ohio project equals two quarters of operating cash flow. Shares closed flat at $225.01 as investors weigh credit risk.
CleanSpark Stock Rises 1.3% as $6.6B AI Lease Faces Funding Gap
CleanSpark shares climbed 1.3% Monday as investors assessed the $6.6B AI data center lease against a projected $739.5M funding shortfall.
Sony Stock Slips as Digital Shift and PS6 Price Concerns Weigh
Sony's ADR dropped 2.4% as digital sales dominate gaming revenue (74%), fueling debate over PS6 pricing and audience scale. Analysts still see upside.
Chipotle Rises 0.8% Despite Jalapeño Recall, H-E-B Joins Expanded Outbreak
Chipotle (CMG) edged up 0.8% after FDA confirmed no ongoing risk from contaminated jalapeños, while the salmonella outbreak expands to eight retail chains including H-E-B and Walmart.
Paramount Gains on $1.88B Bond Request as Warner Merger Timetable Slips
Paramount Skydance (PSKY) rose 1.4% after requesting a $1.88B bond from merger challengers, while delay costs could hit $1.3B, or 34% of 2026 EBITDA.
UnitedHealth Dips 1.5% as Minor Fund Filings Shed Little Light
UnitedHealth shares dropped 1.5% Monday, with newly disclosed fund filings covering just 0.006% of outstanding shares. Volume lagged 31% below average, while Q2 earnings beat expectations.
JCPenney's $15 Trade-In Deal Puts Off-Price Rivals on Alert
JCPenney's new $15 trade-in offer (Aug 28-30) targets off-price shoppers, but rivals like Ross (down 4.1%) remain strong. Analysts question long-term impact.
INVO Fertility Stock Soars 60% on Unprecedented Trading Volume
INVO Fertility (IVF) rocketed 60% on Monday with volume 1,500 times its average, despite no corporate announcement. The stock closed at $1.53 after touching $2.80, with fundamentals still under pressure.